004-494-128-720-663
Full-text?
The full document isn't yet available to us from the patent office.
Abstract
The invention relates to the diagnostic and therapeutic uses of a miRNA molecule or an equivalent thereof wherein a source of said miRNA molecule or equivalent thereof comprises at least 80 nucleotides and comprises a motif having at least 98% identity with the motif represented by SEQ ID NO:1 or a source thereof in a disease and condition associated with EMT (Epithelial to Mesenchymal Transition).
Claims
Download PDF
Document Preview
Document History
- Publication: Sep 6, 2017
-
Application:
Mar 4, 2011
-
Priority:
Mar 4, 2011
-
Priority:
Mar 4, 2011
-
Priority:
Apr 16, 2010
-
Priority:
Mar 4, 2010
